In Depth 23 May 2022 The coming of age of European synthetic biology …staggering,” Cumbers told me. “The cost of starting a startup company has gone down dramatically and the number of startup accelerators such as Y Combinator and IndieBio are enabling that.”… May 23, 2022 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Feb 2025 12 ways biotechnology makes the world more sustainable …African agriculture. Furthermore, even chemical giant Bayer has entered this area through a joint venture with U.S.-based startup Ginkgo Bioworks, with the goal of engineering microorganisms to fix nitrogen for… February 11, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2022 Immunethep receives European Innovation Council funding for clinical trials Immunethep, a Portuguese biotech startup, has been selected by the European Innovation Council (EIC) to receive funding from its EIC Accelerator program. Immunethep will receive initially a €2.5 million ($2.5… October 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2022 Duke Street Bio enters stage with next-generation cancer therapies The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP enzyme inhibitors that treat cancer by blocking the repair of DNA in tumor cells. London-based… May 25, 2022 - 3 minutesmins - By Susannah Rodgers Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2024 12 biotech unicorns revolutionizing the future of healthcare …discovery and development startup helmed by former Merck research chief Roger Perlmutter, Eikon Therapeutics is valued at $3.2 billion. The company’s latest fundraising round was in June last year, in… October 10, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 29 Nov 2017 What’s Going on in the Biotech Ecosystem of Portugal? …startups triple between 2008 to 2015. A study by Portugal Ventures links this growth to a better funding environment and to researchers being more aware that they can start a… November 29, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 4 May 2020 How Are Biotech VC Investments Changing with Covid-19? …Europe discussed their recent experiences, as well as advice for startups navigating this new funding challenge. The coronavirus pandemic has impacted us all in ways that were impossible to predict… May 4, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Inside Labiotech 12 Sep 2019 Prost🍺! Labiotech is the Main Media Partner of the 25th Edition of BIO-Europe! …among many. Startup slams BIO-Europe Startup Slam is a fantastic platform for young startups to pitch their ideas. In addition to gaining visibility, teams who stand out from the crowd… September 12, 2019 - 3 minutesmins - By Yi-Jen Chang Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 May 2024 10 notable pharma and biotech venture capital arms Venture capital firms are vital when it comes to helping biotech startups reach new heights, providing both financial and operational support. Some household names in the industry include the likes… May 23, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2020 T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a spectacularly large Series A round in Europe this year. The Series A round was co-led… September 14, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 3 Apr 2017 Meet the Co-Founder who says DNA is the Next Silicon …Paris, DNA Script produces synthetic DNA using a proprietary template-free enzymatic technology. Most of the manufactured DNA is currently synthesized by chemical means, but this startup has built a new… April 3, 2017 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Sep 2024 Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders The biotech market is still going strong as more startups focused on therapeutic research crop up. Just this week, Italian startup Aptadir Therapeutics launched with $1.6 million to bring a… September 27, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email